In our latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down one of the biggest takeaways from this week’s DEA Administrative Law Judge hearing: the federal conversation around cannabis is becoming much more focused on medicine.
For the first time during the hearing, the FDA publicly acknowledged under oath that cannabis has accepted medical uses while also comparing its safety profile to alcohol and opioids. The testimony offered new insight into how federal health officials are evaluating cannabis as the rescheduling process continues.
Shadd also explains why this matters beyond Schedule III. As regulators, healthcare providers and policymakers continue discussing where cannabinoids fit into modern medicine, attention is increasingly shifting toward pharmaceutical-grade products, standardized dosing, physician oversight and value-based care.
The episode also looks at how companies working in the cannabinoid medicine space could fit into that changing healthcare landscape, why consistency and clinical data matter, and what some of the early lessons from cannabinoid pilot programs may tell us moving forward.
As the ALJ hearing continues, one theme is becoming increasingly clear: the conversation is no longer centered solely on legalization. It’s increasingly becoming about where cannabinoids fit inside the U.S. healthcare system, and how that transition could change the next phase of the industry.
00:00 – Future of Cannabinoid Medicine
00:01:10 – Schedule III Evidence Explained
00:01:28 – DEA Witness on Medical Cannabis
00:01:54 – Healthcare Integration Begins
00:02:18 – Pharmaceutical-Grade Cannabinoids
00:03:17 – Next Generation Cannabinoid Therapies
00:03:40 – CBD Pilot Program Results
00:04:06 – From Wellness to Healthcare
00:04:46 – The Beginning of Cannabinoid Medicine
00:04:58 – Final Thoughts & What’s Next
#Cannabis #MedicalCannabis #Cannabinoids #CBD #ScheduleIII #CannabisNews #Healthcare #CannabisIndustry #DEA #TDRCannabisInFive #ALJHearing #CannabisRescheduling
Want to see last week’s recap?
🎬 https://youtu.be/2R0zMPhMtk8
Want to see more Cannabis Reform?
🎬 https://youtu.be/DlIn-pUCZ7g
🎬 https://youtu.be/WdsecgRKec8
🎬 https://youtu.be/BeyaoxbS2dA
Want to stay updated on Cannabis, Small Cap, AI, and Crypto?
Subscribe to our Daily Baked newsletter:
https://newsletter.thedalesreport.com/subscribe
Find us on social media and podcast platforms:
✅ Facebook: https://www.facebook.com/TheDalesReport
✅ Twitter: https://twitter.com/TheDalesReport
✅ Instagram: https://www.instagram.com/dalesreport
✅ LinkedIn: https://www.linkedin.com/company/the-dales-report/
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackonApplePodcasts
Spotify: https://tinyurl.com/TDRTradeToBlackonSpotify
Website: https://thedalesreport.com/
For copyright matters, contact:
[email protected]
Podcast Disclaimer (Financial Interests)
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.
The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.
By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.
Full Disclosures: https://thedalesreport.com/website-terms-of-use/
